BioForce Nanosciences Holdings, Inc.
BFNH - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$235.51M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $235.51 Million |
|---|---|
| Enterprise Value | $235.51 Million |
| Earnings per Share | $-0.04 |
| Beta | -0.43 |
| Outstanding Shares | 33,544,161 |
Return
| Return on Equity | -4.23% |
|---|---|
| Return on Assets | -4.08% |
| Return on Invested Capital | -26.65% |
Valuation & Multiples
| P/E Ratio | -2340 |
|---|---|
| PEG | 794.85 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -383.71 |
| Enterprise Value to Net Income | -2417 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 10, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About BioForce Nanosciences Holdings, Inc.
3 employees
CEO: Richard James Kaiser
BioForce Nanosciences Holdings, Inc. (BFNH) specializes in providing natural vitamins, minerals, and a variety of other nutritional supplements, along with powders and beverages, intended for individuals across all age demographics. The ...